Early metformin may curb insulin starts in gestational diabetes, while a separate analysis ties a history of the condition to advanced CKM syndrome.
|Videos|December 10, 2014
Leveraging Social Media to Improve Patient Care
Craig Cocchio, PharmD, BCPS, explains how pharmacists have leveraged social media to improve patient care.
Advertisement
Craig Cocchio, PharmD, BCPS, an emergency medicine pharmacist at Robert Wood Johnson University Hospital and clinical assistant professor at the Rutgers University Ernest Mario School of Pharmacy, explains how pharmacists have leveraged social media to improve patient care.
This interview was recorded at the ASHP 2014 Midyear Clinical Meeting in Anaheim, California.
Advertisement
Related to this article
Pharmacy Times previews enlicitide, survodutide, diet and heart failure risk, and pharmacist-led HF care ahead of the AHA Scientific Sessions in Chicago.
Expected in the first half of 2028, the planned separation would create a stand-alone retail pharmacy company with nearly 30,000 pharmacists.
RSV hospitalization raised short-term invasive pneumococcal disease risk, especially among unvaccinated individuals.
ADA guidance ties monitoring choices to therapy, risk, and preference. Brooke Hudspeth, PharmD, explains how pharmacists help individualize the plan.
The provider-administered IL-23 inhibitor improved ACR20 response vs placebo after 2 doses in the phase 3 INSPIRE-1 and INSPIRE-2 trials.
Two Kidney Week 2026 posters suggest remnant cholesterol–based markers may help stratify CKD severity and cardiovascular death risk on hemodialysis.
A pharmacy technician reflects on 3 patient encounters that reshaped his
understanding of what a real patient requires.
Advertisement
Advertisement
Trending on Pharmacy Times
1
What Drives First-Line Immunotherapy Selection in NSCLC? Data, Payers, and Habit
2
FDA Grants Priority Review to Zanubrutinib Plus Rituximab for Previously Untreated MCL
3
AHA 2026: Insights on Oral PCSK9, Survodutide, and HF Care Come to Chicago
4
October Neurology News: Huntington Disease Gene Therapy, Remibrutinib in MS, and AI Medical Advice
5